Unknown

Dataset Information

0

Serum paraoxonase level and paraoxonase polymorphism in patients with acromegaly.


ABSTRACT: BACKGROUND:Acromegalic patients have increased cardiometabolic risk factors due to an elevation of growth hormone (GH) levels. Human serum paraoxonase (PON), a high-density lipoprotein (HDL)-related enzyme, is one of the major bioscavengers and decreases the oxidation of low-density lipoprotein (LDL), a key regulator in the pathogenesis of atherosclerosis. In this study, we investigated a potential relationship between serum PON levels or PON polymorphisms and acromegaly. METHODS:A total of 48 acromegalic patients and 44 healthy controls were included in this study. Serum GH levels, insulin-like growth factor-1 levels and lipid profiles were measured. Serum PON levels, as well as PON 1 L55M and Q192R gene polymorphisms, were examined. RESULTS:No significant differences were found in terms of age, gender, presence of diabetes, serum LDL cholesterol (LDL-C), HDL-C, or triglyceride levels between the case and control groups (P?>?0.05). A statistically significant difference was found in serum PON levels between the cases and controls (P?=?0.007). The median serum PON level was 101?±?63.36?U/l in the case group and 63?±?60.50?U/l in the control group. There was a significant correlation between serum PON levels and IGF-1 levels (P?=?0.004, r?=?0.319); however, no significant differences were found in PON1 L55M and PON Q192R polymorphisms between the patients and controls (P?=?0.607 and P?=?0.308, respectively). In addition, no significant differences were found in serum PON levels in acromegalic patients who were and were not in remission (P?=?0.385), nor between those with PON1 L55M and Q192R polymorphisms (P?=?0.161 and P?=?0.336, respectively). CONCLUSIONS:Elevated serum PON levels were detected in acromegalic patients, independently of their remission status. This suggests protective effects for cardiometabolic risk parameters.

SUBMITTER: Arpaci D 

PROVIDER: S-EPMC6837684 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Serum paraoxonase level and paraoxonase polymorphism in patients with acromegaly.

Arpaci Dilek D   Karakas Celik Sevim S   Can Murat M   Ermiş Esra E   Kuzu Fatih F   Kokturk Furuzan F   Hamamcioglu Ayse Ceylan AC   Dursun Ahmet A   Bayraktaroglu Taner T  

Redox report : communications in free radical research 20160215 6


<h4>Background</h4>Acromegalic patients have increased cardiometabolic risk factors due to an elevation of growth hormone (GH) levels. Human serum paraoxonase (PON), a high-density lipoprotein (HDL)-related enzyme, is one of the major bioscavengers and decreases the oxidation of low-density lipoprotein (LDL), a key regulator in the pathogenesis of atherosclerosis. In this study, we investigated a potential relationship between serum PON levels or PON polymorphisms and acromegaly.<h4>Methods</h4>  ...[more]

Similar Datasets

| S-EPMC3085023 | biostudies-literature
| S-EPMC8343737 | biostudies-literature
| S-EPMC4629460 | biostudies-literature
| S-EPMC2827704 | biostudies-literature
| S-EPMC8116103 | biostudies-literature
| S-EPMC10065381 | biostudies-literature
| S-EPMC10741051 | biostudies-literature
| S-EPMC4419403 | biostudies-literature
| S-EPMC5214702 | biostudies-literature
| S-EPMC6733492 | biostudies-literature